Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: preliminary findings.

Brain, behavior, and immunity - 1 Oct 2012

Jim Heather S L, Park Jong Y, Permuth-Wey Jennifer, Rincon Maria A, Phillips Kristin M, Small Brent J, Jacobsen Paul B

Abstract excerpt

BACKGROUND: Fatigue is a common and distressing side effect of androgen deprivation therapy (ADT) for prostate cancer. The goal of the current study was to examine the relationship between changes in fatigue following initiation of ADT and single nucleotide polymorphisms (SNPs) in three pro-inflammatory cytokine genes: interleukin-1 beta (IL1B), interleukin-6 (IL6), and tumor necrosis factor alpha (TNFA)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgen Antagonists
Share to Androgens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Confidence Intervals

Share to Demography

Share to Depression

Share to Fatigue

Share to Interleukin-1beta

Share to Interleukin-6

Source

Open in PubMed Open full text

Identifiers

PMID: 22475653
DOI: 10.1016/j.bbi.2012.03.001
PMCID: PMC3399038

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: preliminary findings.PMID 22475653Read ↗

Cytokine genetic variations and fatigue among patients with breast cancer.Semantic proximity Read ↗

Interleukin-6 promoter variants, prostate cancer risk, and survival.Semantic proximity Read ↗

Genomic Variants Associated With Cancer-Related Fatigue: A Systematic ReviewSemantic proximity Read ↗

Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial.Semantic proximity Read ↗

A systematic review of the association between fatigue and genetic polymorphisms.Semantic proximity Read ↗

Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings.Semantic proximity Read ↗

Exploring Genetic Attributions Underlying Radiotherapy-Induced Fatigue in Prostate Cancer Patients.Semantic proximity Read ↗

Association between interleuleukin-1β polymorphism (rs16944) and biomarkers levels in Iraqi patients with prostate cancer.Semantic proximity Read ↗

Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patients.Semantic proximity Read ↗

Association between IL-1 β polymorphism (rs16944) and Biomarkers levels in Iraqi patients with prostate cancerSemantic proximity Read ↗

Preliminary evidence of an association between a functional interleukin-6 polymorphism and fatigue and sleep disturbance in oncology patients and their family caregivers.Semantic proximity Read ↗

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.